Nocodazole increases the ERK activity to enhance MKP-1 expression which inhibits p38 activation induced by TNF-α

Molecular and Cellular Biochemistry

Volumn 364, Issue 1-2, 2012, Pages 373-380

  Guo, Xiangrui ^a   Zhang, Xueying ^b   Li, Yajing ^b   Guo, Yuanyuan ^b   Wang, Jing ^b   Li, Yan ^b   Shen, Beifen ^b   Sun, Dejun ^a   Zhang, Jiyan ^b  

^a JILIN UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

ERK; Microtubules; MKP 1; Nocodazole; P38

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DACTINOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; NOCODAZOLE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; RAT; ULTRAVIOLET RADIATION;

ANIMALS; BUTADIENES; CELL CYCLE; CELL LINE; DACTINOMYCIN; DUAL SPECIFICITY PHOSPHATASE 1; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION; IMIDAZOLES; MAP KINASE KINASE 4; MICE; MICROTUBULES; NITRILES; NOCODAZOLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RATS; RNA; SIGNAL TRANSDUCTION; TUBULIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863982964     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1239-5     Document Type: Article

References (32)

1. Han J, Lee JD, Bibbs L, Ulevitch RJ (1994) A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811 (Pubitemid 24266145)
2. Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D (1994) A novel kinase cascade triggered by stress and heat shock that stimulates MAPK-AP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78:1027-1037 (Pubitemid 24292330)
3. Zarubin T, Han J (2005) Activation and signaling of the p38 MAP kinase pathway. Cell Res 15:11-18 (Pubitemid 41653958)
4. Karin M (1995) The regulation of AP-1 activity by mitogenactivated protein kinases. J Biol Chem 270:16483-16486
5. Lin A (2003) Activation of the JNK signaling pathway: breaking the brake on apoptosis. Bioessays 25:17-24 (Pubitemid 36093321)
6. Franklin CC, Kraft AS (1997) Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem 272:16917-16923 (Pubitemid 27289792)
7. Bhattacharyya S, Brown DE, Brewer JA, Vogt SK, Muglia LJ (2007) Macrophage glucocorticoid receptors regulate Toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109:4313-4319 (Pubitemid 46743398)
8. Zhu QY, Liu Q, Chen JX, Lan K, Ge BX (2010) MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophage. J Immunol 185:7435-7442
9. Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 255:253-265 (Pubitemid 38525281)
10. Subbaramaiah K, Hart JC, Norton L, Dannenberg AJ (2000) Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. J Biol Chem 275:14838-14845
11. Nagata K, Puls A, Futter C, Aspenstrom P, Schaefer E, Nakata T (1998) The MAP kinase kinase kinase MLK2 co-localizes with activated JNK along microtubules and associates with kinesin superfamily motor KIF3. EMBO J 17:149-158 (Pubitemid 28041056)
12. Gundersen GG, Cook TA (1999) Microtubules and signal transduction. Curr Opin Cell Biol 11:81-94 (Pubitemid 29084135)
13. Verhey KJ, Rapoport TA (2001) Kinesin carries the signal. Trends Biochem Sci 26:545-550 (Pubitemid 32823439)
14. Morrison DK, Davis RJ (2003) Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu Rev Cell Dev Biol 19:91-118 (Pubitemid 37487344)
15. Cheung PY, Zhang Y, Long J, Lin S, Zhang M, Jiang Y (2004) p150Glued, Dynein, and microtubules are specifically required for activation of MKK3/6 and p38 MAPKs. J Biol Chem 279:45308-45311 (Pubitemid 39491512)
16. Prickett TD, Brautigen DL (2007) Cytokine activation of p38 mitogen-activated protein kinase and apoptosis is opposed by alpha-4 targeting of protein phosphatase 2A for site-specific dephosphorylation of MEK3. Mol Cell Biol 27:4217-4227 (Pubitemid 46906547)
17. Schmid-Alliana A, Menou L, Manie S, Schmid-Antomarchi H, Millet MA, Giuriato S (1998) Microtubule integrity regulates srclike and extracellular signal-regulated kinase activities in human pro-monocytic cells: importance for interleukin-1 production. J Biol Chem 273:3394-3400 (Pubitemid 28109757)
18. Lee LF, Li G, Templeton DJ, Ting JP (1998) Paclitaxel (Taxol) - induced gene expression and cell death are both mediated by the activation of c-Jun. NH2-terminal kinase (JNK/SAPK). J Biol Chem 273:28253-28260 (Pubitemid 28496124)
19. Wang TH, Wang HS, Ichijo H, Giannakakou P, Foster JS, Fojo T (1998) Microtubule-interfering agents activate c-Jun. N-terminal kinase/stress- activated protein kinase through both Ras and apoptosis signal-regulating kinase pathways. J Biol Chem 273:4928-4936 (Pubitemid 28108645)
20. Fortin J, Patenaude A, Deschesnes RG, Cote MF, Petitclerc E, Gaudreault RC (2010) ASK1-p38 pathway is important for anoikis induced by microtubule-targeting aryl chloroethylureas. J Pharm Pharm Sci 13:175-190
21. De Brabander MJ, Van de Veire RML, Aerts FEM, Borgers M, Janssen PAJ (1976) The effects of methyl (5-(2-Thienylcarbonyl)-IH-benzimidazol-2-yl] carbamate, (R 17934; NSC 238159), a new synthetic antitumoral drug interfering with microtubules, on mammalian cells cultured in vitro. Cancer Res 36:905-916
22. Lee JC, Field DJ, Lee LL (1980) Effects of nocodazole on structures of calf brain tubulin. Biochemistry 19:6209-6215 (Pubitemid 11134703)
23. Zhang J, Bui TN, Xiang J, Lin A (2006) Cyclic AMP inhibits p38 activation via CREB-induced dynein light chain. Mol Cell Biol 26:1223-1234 (Pubitemid 43202551)
24. Zhang J, Shen B, Lin A (2007) Novel strategies for inhibition of the p38 MAPK pathway. Trends Pharmaco Sci 28:286-295 (Pubitemid 46818466)
25. Brancho D, Tanaka N, Jaeschke A, Ventura JJ, Kelkar N, Tanaka Y (2003) Mechanism of p38 MAP kinase activation in vivo. Genes Dev 17:1969-1978 (Pubitemid 36999324)
26. Derijard B, Raingeaud J, Barrett T, Wu IH, Han J, Ulevitch RJ (1995) Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682-685
27. Lin A, Minden A, Martinetto H, Claret FX, Lange-Carter C, Mercurio F (1995) Identification of a dual specificity kinase that activates the Jun. kinases and p38-Mpk2. Science 268:286-290
28. Han J, Lee JD, Jiang Y, Li Z, Feng L, Ulevitch RJ (1996) Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem 271:2886-2891
29. Zhang J, Wang Q, Zhu N, Yu M, Shen B, Xiang J (2008) Cyclic AMP inhibits JNK activation by CREB-mediated induction of c-FLIPL and MKP-1, thereby antagonizing UV-induced apoptosis. Cell Death Differ 15:1654-1662
30. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to Insulin and NGF. Cell 65:663-675
31. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS (1998) Identification of a novel inhibitor of mitogenactivated protein kinase kinase. J Biol Chem 273:18623-18632 (Pubitemid 28334795)
32. Keyse SM (2008) Dual-specificity MAP kinase phosphatases (MKPs) and cancer. Cancer Metastasis Rev 27:253-261